Industry: Chemical & Material
Published Date: 2026-04-21
Pages: 141 Pages
Report ld: 6552232
Request Sample
Customized Report
(-)-Blebbistatin Market Size(US$)

CAGR 2026-2032
3.8%
Market Size,2032
USD 14.94
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global (-)-Blebbistatin market was valued at US$ 11.55 million in 2025 and is anticipated to reach US$ 14.94 million by 2032, at a CAGR of 3.8% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on (-)-Blebbistatin competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
(-)-Blebbistatin (CAS 856925-71-8) is a yellow solid, a cell-permeable non-muscle myosin II ATPase inhibitor, which can be inactivated by blue light.
(-)-Blebbistatin is a commonly used compound in biochemical research, primarily employed to inhibit the activity of myosin II, thus blocking muscle contraction. Currently, in the field of biomedicine, there is a gradual increase in the demand for (-)-Blebbistatin, particularly as its applications continue to expand in cell biology and biomedical research. The market size is relatively small, mainly constrained by its high cost and specialized use. However, with the advancement of biomedical technology and a deeper understanding of cellular functions, it is expected that the market for (-)-Blebbistatin will expand in the future and has the potential to become an essential tool for broader applications.
This report delivers a comprehensive overview of the global (-)-Blebbistatin market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding (-)-Blebbistatin. The (-)-Blebbistatin market size, estimates, and forecasts are provided in terms of output/shipments (Ton) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global (-)-Blebbistatin market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist (-)-Blebbistatin manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for (-)-Blebbistatin manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines (-)-Blebbistatin production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes (-)-Blebbistatin consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 (-)-Blebbistatin Market Overview
1.1 Product Definition
1.2 (-)-Blebbistatin by Type
1.2.1 Global (-)-Blebbistatin Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Purity 97%
1.2.3 Purity 98%
1.2.4 Purity 99%
1.2.5 Others
1.3 (-)-Blebbistatin by Application
1.3.1 Global (-)-Blebbistatin Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Industries
1.3.3 Laboratories
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global (-)-Blebbistatin Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global (-)-Blebbistatin Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global (-)-Blebbistatin Production Estimates and Forecasts (2021–2032)
1.4.4 Global (-)-Blebbistatin Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global (-)-Blebbistatin Production Market Share by Manufacturers (2021–2026)
2.2 Global (-)-Blebbistatin Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of (-)-Blebbistatin, Industry Ranking, 2024 vs 2025
2.4 Global (-)-Blebbistatin Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global (-)-Blebbistatin Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of (-)-Blebbistatin, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of (-)-Blebbistatin, Product Offerings and Applications
2.8 Global Key Manufacturers of (-)-Blebbistatin, Date of Entry into the Industry
2.9 (-)-Blebbistatin Market Competitive Situation and Trends
2.9.1 (-)-Blebbistatin Market Concentration Rate
2.9.2 Top 5 and Top 10 Global (-)-Blebbistatin Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 (-)-Blebbistatin Production by Region
3.1 Global (-)-Blebbistatin Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global (-)-Blebbistatin Production Value by Region (2021–2032)
3.2.1 Global (-)-Blebbistatin Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of (-)-Blebbistatin by Region (2027–2032)
3.3 Global (-)-Blebbistatin Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global (-)-Blebbistatin Production Volume by Region (2021–2032)
3.4.1 Global (-)-Blebbistatin Production by Region (2021–2026)
3.4.2 Global Forecasted Production of (-)-Blebbistatin by Region (2027–2032)
3.5 Global (-)-Blebbistatin Market Price Analysis by Region (2021–2032)
3.6 Global (-)-Blebbistatin Production, Value, and Year-over-Year Growth
3.6.1 North America (-)-Blebbistatin Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe (-)-Blebbistatin Production Value Estimates and Forecasts (2021–2032)
3.6.3 China (-)-Blebbistatin Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan (-)-Blebbistatin Production Value Estimates and Forecasts (2021–2032)
4 (-)-Blebbistatin Consumption by Region
4.1 Global (-)-Blebbistatin Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global (-)-Blebbistatin Consumption by Region (2021–2032)
4.2.1 Global (-)-Blebbistatin Consumption by Region (2021–2026)
4.2.2 Global (-)-Blebbistatin Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America (-)-Blebbistatin Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America (-)-Blebbistatin Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe (-)-Blebbistatin Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe (-)-Blebbistatin Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific (-)-Blebbistatin Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific (-)-Blebbistatin Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa (-)-Blebbistatin Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa (-)-Blebbistatin Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global (-)-Blebbistatin Production by Type (2021–2032)
5.1.1 Global (-)-Blebbistatin Production by Type (2021–2026)
5.1.2 Global (-)-Blebbistatin Production by Type (2027–2032)
5.1.3 Global (-)-Blebbistatin Production Market Share by Type (2021–2032)
5.2 Global (-)-Blebbistatin Production Value by Type (2021–2032)
5.2.1 Global (-)-Blebbistatin Production Value by Type (2021–2026)
5.2.2 Global (-)-Blebbistatin Production Value by Type (2027–2032)
5.2.3 Global (-)-Blebbistatin Production Value Market Share by Type (2021–2032)
5.3 Global (-)-Blebbistatin Price by Type (2021–2032)
6 Segment by Application
6.1 Global (-)-Blebbistatin Production by Application (2021–2032)
6.1.1 Global (-)-Blebbistatin Production by Application (2021–2026)
6.1.2 Global (-)-Blebbistatin Production by Application (2027–2032)
6.1.3 Global (-)-Blebbistatin Production Market Share by Application (2021–2032)
6.2 Global (-)-Blebbistatin Production Value by Application (2021–2032)
6.2.1 Global (-)-Blebbistatin Production Value by Application (2021–2026)
6.2.2 Global (-)-Blebbistatin Production Value by Application (2027–2032)
6.2.3 Global (-)-Blebbistatin Production Value Market Share by Application (2021–2032)
6.3 Global (-)-Blebbistatin Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Adooq Bioscience
7.1.1 Adooq Bioscience (-)-Blebbistatin Company Information
7.1.2 Adooq Bioscience (-)-Blebbistatin Product Portfolio
7.1.3 Adooq Bioscience (-)-Blebbistatin Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Adooq Bioscience Main Business and Markets Served
7.1.5 Adooq Bioscience Recent Developments/Updates
7.2 BioCrick
7.2.1 BioCrick (-)-Blebbistatin Company Information
7.2.2 BioCrick (-)-Blebbistatin Product Portfolio
7.2.3 BioCrick (-)-Blebbistatin Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 BioCrick Main Business and Markets Served
7.2.5 BioCrick Recent Developments/Updates
7.3 ChemScence
7.3.1 ChemScence (-)-Blebbistatin Company Information
7.3.2 ChemScence (-)-Blebbistatin Product Portfolio
7.3.3 ChemScence (-)-Blebbistatin Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 ChemScence Main Business and Markets Served
7.3.5 ChemScence Recent Developments/Updates
7.4 Key Organics
7.4.1 Key Organics (-)-Blebbistatin Company Information
7.4.2 Key Organics (-)-Blebbistatin Product Portfolio
7.4.3 Key Organics (-)-Blebbistatin Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Key Organics Main Business and Markets Served
7.4.5 Key Organics Recent Developments/Updates
7.5 AK Scientific
7.5.1 AK Scientific (-)-Blebbistatin Company Information
7.5.2 AK Scientific (-)-Blebbistatin Product Portfolio
7.5.3 AK Scientific (-)-Blebbistatin Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 AK Scientific Main Business and Markets Served
7.5.5 AK Scientific Recent Developments/Updates
7.6 APExBIO Technology
7.6.1 APExBIO Technology (-)-Blebbistatin Company Information
7.6.2 APExBIO Technology (-)-Blebbistatin Product Portfolio
7.6.3 APExBIO Technology (-)-Blebbistatin Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 APExBIO Technology Main Business and Markets Served
7.6.5 APExBIO Technology Recent Developments/Updates
7.7 Bio-Techne
7.7.1 Bio-Techne (-)-Blebbistatin Company Information
7.7.2 Bio-Techne (-)-Blebbistatin Product Portfolio
7.7.3 Bio-Techne (-)-Blebbistatin Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Bio-Techne Main Business and Markets Served
7.7.5 Bio-Techne Recent Developments/Updates
7.8 Glentham Life Sciences
7.8.1 Glentham Life Sciences (-)-Blebbistatin Company Information
7.8.2 Glentham Life Sciences (-)-Blebbistatin Product Portfolio
7.8.3 Glentham Life Sciences (-)-Blebbistatin Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Glentham Life Sciences Main Business and Markets Served
7.8.5 Glentham Life Sciences Recent Developments/Updates
7.9 CSNpharm
7.9.1 CSNpharm (-)-Blebbistatin Company Information
7.9.2 CSNpharm (-)-Blebbistatin Product Portfolio
7.9.3 CSNpharm (-)-Blebbistatin Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 CSNpharm Main Business and Markets Served
7.9.5 CSNpharm Recent Developments/Updates
7.10 DC Chemicals
7.10.1 DC Chemicals (-)-Blebbistatin Company Information
7.10.2 DC Chemicals (-)-Blebbistatin Product Portfolio
7.10.3 DC Chemicals (-)-Blebbistatin Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 DC Chemicals Main Business and Markets Served
7.10.5 DC Chemicals Recent Developments/Updates
7.11 Merck
7.11.1 Merck (-)-Blebbistatin Company Information
7.11.2 Merck (-)-Blebbistatin Product Portfolio
7.11.3 Merck (-)-Blebbistatin Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 Merck Main Business and Markets Served
7.11.5 Merck Recent Developments/Updates
7.12 BOC Sciences
7.12.1 BOC Sciences (-)-Blebbistatin Company Information
7.12.2 BOC Sciences (-)-Blebbistatin Product Portfolio
7.12.3 BOC Sciences (-)-Blebbistatin Production, Value, Price, and Gross Margin (2021–2026)
7.12.4 BOC Sciences Main Business and Markets Served
7.12.5 BOC Sciences Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 (-)-Blebbistatin Industry Chain Analysis
8.2 (-)-Blebbistatin Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 (-)-Blebbistatin Production Modes and Processes
8.4 (-)-Blebbistatin Sales and Marketing
8.4.1 (-)-Blebbistatin Sales Channels
8.4.2 (-)-Blebbistatin Distributors
8.5 (-)-Blebbistatin Customer Analysis
9 (-)-Blebbistatin Market Dynamics
9.1 (-)-Blebbistatin Industry Trends
9.2 (-)-Blebbistatin Market Drivers
9.3 (-)-Blebbistatin Market Challenges
9.4 (-)-Blebbistatin Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for (-)-Blebbistatin was estimated to be worth US$ 11.55 million in 2025 and is projected to reach US$ 14.94 million, growing at a CAGR of 3.8% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 140
USD 3950.00
(Single User License)
The global (-)-Blebbistatin market is projected to grow from US$ 11.2 million in 2024 to US$ 14.4 million by 2031, at a CAGR of 3.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-21
Pages: 165
USD 4900.00
(Single User License)
The global market for (-)-Blebbistatin was valued at US$ 11.2 million in the year 2024 and is projected to reach a revised size of US$ 14.4 million by 2031, growing at a CAGR of 3.8% during the forecast period.
Published Date: 2025-02-15
Pages: 98
USD 2900.00
(Single User License)
The global (-)-Blebbistatin market size was US$ 11.2 million in 2024 and is forecast to a readjusted size of US$ 14.4 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 94
USD 4250.00
(Single User License)
The global market for (-)-Blebbistatin was estimated to be worth US$ 11.2 million in 2024 and is forecast to a readjusted size of US$ 14.4 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 113
USD 3950.00
(Single User License)
(-)-Blebbistatin (CAS 856925-71-8) is a yellow solid, a cell-permeable non-muscle myosin II ATPase inhibitor, which can be inactivated by blue light.
Published Date: 2024-04-12
Pages: 106
USD 4900.00
(Single User License)
(-)-Blebbistatin (CAS 856925-71-8) is a yellow solid, a cell-permeable non-muscle myosin II ATPase inhibitor, which can be inactivated by blue light.
Published Date: 2024-02-26
Pages: 97
USD 2900.00
(Single User License)
(-)-Blebbistatin (CAS 856925-71-8) is a yellow solid, a cell-permeable non-muscle myosin II ATPase inhibitor, which can be inactivated by blue light.
Published Date: 2024-01-10
Pages: 118
USD 3950.00
(Single User License)
The global market for (-)-Blebbistatin was estimated to be worth US$ 11.55 million in 2025 and is projected to reach US$ 14.94 million, growing at a CAGR of 3.8% from 2026 to 2032.
Published: 2026-07-14
Pages: 140
The global (-)-Blebbistatin market is projected to grow from US$ 11.2 million in 2024 to US$ 14.4 million by 2031, at a CAGR of 3.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-21
Pages: 165
The global market for (-)-Blebbistatin was valued at US$ 11.2 million in the year 2024 and is projected to reach a revised size of US$ 14.4 million by 2031, growing at a CAGR of 3.8% during the forecast period.
Published: 2025-02-15
Pages: 98
The global (-)-Blebbistatin market size was US$ 11.2 million in 2024 and is forecast to a readjusted size of US$ 14.4 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 94
The global market for (-)-Blebbistatin was estimated to be worth US$ 11.2 million in 2024 and is forecast to a readjusted size of US$ 14.4 million by 2031 with a CAGR of 3.8% during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 113
(-)-Blebbistatin (CAS 856925-71-8) is a yellow solid, a cell-permeable non-muscle myosin II ATPase inhibitor, which can be inactivated by blue light.
Published: 2024-04-12
Pages: 106
(-)-Blebbistatin (CAS 856925-71-8) is a yellow solid, a cell-permeable non-muscle myosin II ATPase inhibitor, which can be inactivated by blue light.
Published: 2024-02-26
Pages: 97
(-)-Blebbistatin (CAS 856925-71-8) is a yellow solid, a cell-permeable non-muscle myosin II ATPase inhibitor, which can be inactivated by blue light.
Published: 2024-01-10
Pages: 118
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now